Cleerly is a health technology company focused on combating cardiovascular disease through its innovative, AI-driven platform. Founded by Dr. James K. Min, the company's mission is to prevent heart attacks by shifting the paradigm of heart care from reactive to proactive. Cleerly's FDA-cleared solutions analyze coronary computed tomography angiography (CCTA) scans to quantify and characterize atherosclerotic plaque, providing physicians with a more precise understanding of a patient's heart disease risk. This approach aims to deliver personalized, life-saving treatment plans long before a cardiac event occurs.

Founded in

France